1Cancer Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; 2Division of Nuclear Medicine, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah; 3Department of Radiology, University of California, San Francisco, California; 4Division of Nuclear Medicine, Department of Radiology, University of Iowa, Iowa City, Iowa; 5Di...

The field of nuclear medicine will rely increasingly on the discovery, proper evaluation, and clinical use of molecular imaging probes and on collaborations. Collaborations will include new initiatives among experts already involved in the field and with researchers, technologists, and clinicians from different areas of science and medicine. This article serves to highlight some of the opportun...

Objective(s): In recent years, the application of radiopharmaceuticals in nuclear medicine has increased substantially. Following the diagnostic procedures performed in nuclear medicine departments, such as myocardial perfusion imaging, patients generally receive considerable doses of radiation. Normally, radiation-induced DNA damages are expected following exposure to a low-dose ionizing radia...

The last decade has witnessed significant advances in medicine, particularly in the understanding of pathological processes at the molecular level, aided by the development in parallel of ever more sophisticated diagnostic imaging technologies. The increase of chronic diseases worldwide, including cancer, has spurred the development of a new biomedical research discipline, called Molecular Imag...

introduction: scattered photon is one of the main defects that degrade the quality and quantitative accuracy of nuclear medicine images. accurate estimation of scatter in projection data of spect is computationally extremely demanding for activity distribution in uniform and non-uniform dense media. methods: the objective of this paper is to develop and validate a scatter correction technique t...

Although the multidisciplinary nature of nuclear medicine (NM) and clinical molecular imaging is a key strength of the specialty, the breadth of disciplines involved in the practice of NM creates challenges for education and training. The evolution of NM science and technology-and the practice of clinical molecular imaging and theranostics-has created a need for changes in the approach to speci...

introduction: in the current study we evaluated the incremental value of lateral pelvic lymphoscintigraphy imaging of endometrial or cervical cancer patients who underwent sentinel node mapping. methods: operable endometrial and cervical cancer patients without clinical or paraclinical evidence of lymph node involvement were included in the study. the day before surgery the patients were sent ...

The publication in June 2007 of a White Paper in Multimodality Imaging [1] marked the recognition by both the European Society of Radiology (ESR) and the European Association of Nuclear Medicine (EANM) of the importance of coordinating future work practices to incorporate multimodality imaging. The white paper outlined principles and an approach to cooperation between both societies in response...